The efficacy of selective serotonin re-uptake inhibitors in depression: A meta-analysis of studies against tricyclic antidepressants

Journal of Psychopharmacology

Volumn 8, Issue 4, 1994, Pages 238-249

  Anderson, I M ^a   Tomenson, B M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

depression; treatment; efficacy; meta analysis; selective serotonin re uptake inhibitors; tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; METHODOLOGY; PRIORITY JOURNAL; RATING SCALE; STATISTICAL ANALYSIS;

EID: 0028019316     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/026988119400800407     Document Type: Article

References (131)

1. Altamura A.C., Percudani M., Guercetti G., Invernizzi G. (1989) Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitriptyline. Int Clin Psychopharmacol 4: 103-106
2. Amin M.M., Ananth J.V., Coleman B.S., Darcourt G., Farkas T., Goldstein B., Lapierre Y.D., Paykel E., Wakelin J.S. (1984) Fluvoxamine: antidepressant effects confirmed in a placebo-controlled international study. Clin Neuropharmacol 7(Suppl 1): S316-S317
3. Amore M., Bellini M., Berardi D., Berlinzani L., Cervino G., Cremonini A., Ferrari G., Innamorati A. (1989) Double-blind comparison of fluvoxamine and imipramine in depressed patients. Curr Ther Res 46: 815-820
4. Ansseau M., Gabriels A., Loyens J., Bartholome F., Evrard J., De Nayer A., Linhart R., Wirtz J., Bruynooghe F., Surinx K., Clarysse H., Marganne R., Papart P. (1993) A double-blind comparison of paroxetine and fluvoxamine in major depression. Eur Neuropsychopharmacol 3: 323-324
5. Baron B.M., Ogden A.M., Siegel B.W., Stegeman J., Ursillo R.C., Dudley M.W. (1988) Rapid down regulation of β-adrenoreceptors by co-administration of desipramine and fluoxetine. Eur J Pharmacol 154: 125-134
6. Bascara L. (1989) A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients. Acta Psychiatr Scand 80: 141-142
7. Battegay R., Hager M., Rauchfleisch U. (1985) Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric out-patient clinic (pilot study). Neuropsychobiology 13: 31-37
8. Bech P. (1990) A meta-analysis of the antidepressant properties of serotonin reuptake inhibitors. Int Rev Psychol 2: 207-211
9. Bignamini A., Rapisarda V. (1992) A double-blind multicentre study of paroxetine and amitriptyline in depressed out-patients. Int Clin Psychopharmacol 6: 37-41
10. Blashki T.G., Mowbray R., Davies B. (1971) Controlled trial of amitriptyline in General Practice. Br Med J 1: 133-138
11. Bouchard J.M., Delaunay J., Delisle J-P., Grassel N., Mermberg P.F., Molczadzki, Pagot R., Richou H., Robert G., Ropert R., Schuller E., Verdeau-Pailles J., Zarifan E., Hopfner Petersen H.E. (1987) Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients. Acta Psychiatr Scand 76: 583-592
12. Boyer W.F., Feighner J.P. (1991) Other potential indications for selective serotonin re-uptake inhibitors. In Feighner J P, Boyer W F (eds), Selective serotonin re-uptake inhibitors: the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline. John Wiley & Sons, Chichester, pp. 119-132
13. Bramanti P., Ricci R.M., Roncari R., Bilone F., Inga F., Teti V., De Cristofaro A.M., Ceccarelli G., Di Perri R., Candela L. (1988) An Italian multicentre experience with fluvoxamine, a new antidepressant drug, versus imipramine. Curr Ther Res 43: 718-724
14. Bremner J.D. (1984) Fluoxetine in depressed patients: a comparison with imipramine. J Clin Psychiatr 45: 414-419
15. Bressa G.M., Brugnoli R., Pancheri P. (1989) A double-blind study of fluoxetine and imipramine in major depression. Int Clin Psychopharmacol 4: 69-73
16. Byerley W.F., Reimherr F.W., Wood D.R., Grosser B.I. (1988) Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of out-patients with major depression. J Clin Psychopharmacol 8: 112-115
17. Byrne M.M. (1989) Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients. Acta Psychiatr Scand 80: 138-139
18. Chouinard G. (1985) A double blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of out-patients with major depressive disorder. J Clin Psychiatr 46: 32-37
19. Cohen J. (1977) Statistical power analysis for the behavioral sciences. Academic Press Inc., Orlando
20. Cohn J.B., Wilcox C. (1985) A comparison of fluoxetine, imipramine, and placebo in patients with depressive disorder. J Clin Psychiatr 46: 26-31
21. Cohn J.B., Collins G., Ashbrook E., Wernicke J.F. (1989) A comparison of fluoxetine, imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 4: 313-322
22. Cohn J.B., Crowder J.E., Wilcox C.S., Ryan P.J. (1990a) A placebo-and imipramine-controlled study of paroxetine. Psychopharmacol Bull 26: 185-189
23. Cohn C.K., Shrivastava R., Mendels J., Cohn J.B., Fabre L.F., Claghorn J.L., Dessain E.C., Itil T.M., Lautin A. (1990b) Double-blind, multicenter comaprison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatr 51: 28-33
24. Coleman B.S., Block B.A. (1982) Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine. Prog Neuro-psychopharmacol 6: 475-478
25. Collins R., Gray R., Godwin J., Peto R. (1987) Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Stat Med 6: 245-250
26. Corne S.J., Hall J.R. (1989) A double-blind comparative study of fluoxetine and dothiepin in the treatment of depression in general practice. Int Clin Psychopharmacol 4: 245-254
27. Danish University Antidepressant Group (1986) Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology 90: 131-138
28. Danish University Antidepressant Group (1990) Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicentre study. J Affective Disord 18: 289-299
29. Davis J.M., Wang Z., Janicak P.G. (1993) A quantitative analysis of clinical drug trials for the treatment of affective disorders. Psychopharmacol Bull 29: 175-181
30. de Jonghe F., Swinkels J., Tuynman-Qua H. (1991a) Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression. Pharmacopsychiatry 21: 21-27
31. de Jonghe F., Ravelli D.P., Tuynman-Qua H. (1991b) A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression. Pharmacopsychiatry 24: 62-67
32. De Wilde J E M, Doogan D.P. (1982) Fluvoxamine and chlorimipramine in endogenous depression. J Affective Disord 4: 249-259
33. De Wilde J.E., Mertens C., Wakelin J.S. (1983) Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing. Br J Clin Pharmacol 15: 427S-431S
34. De Wilde J., Spiers R., Mertens C., Bartholome F., Schotte G., Leyman S. (1993) A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients. Acta Psychiatr Scand 87: 141-145
35. Dick P., Ferrero E. (1983) A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine. Br J Clin Pharmacol 15: 419S-425S
36. Dominguez R.A., Goldstein B.J., Jacobson A.F., Steinbook R.M. (1985) A double-blind placebo-controlled study of fluvoxamine and imipramine in depression. J Clin Psychiatr 46: 84-87
37. Dunbar G.C., Cohn J.B., Fabre L.F., Feighner J.P., Fieve R.R., Mendels J., Shrivastava R.K. (1991) A comparison of paroxetine, imipramine and placebo in depressed out-patients. Br J Psychiatr 159: 394-398
38. Dunner D.L., Cohn J.B., Walshe T., Cohn C.K., Feighner J.P., Rieve R.R., Halikas J.P., Hartford J.T., Hearst E.D., Settle E.C., Menolascino R.J., Muller D.J. (1992) Two combined, multicentre double-blind studies or paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatr 53: 57-60
39. Edwards J.G. (1992) Selective serotonin reuptake inhibitors: A modest though welcome advance in the treatment of depression. Br Med J 304: 1644-1645
40. Fabre L.F., Scharf M.B., Itil T.M. (1991) Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: A clinical study. J Clin Psychiatr 52: 62-67
41. Fawcett J., Zajecka J.M., Kravitz H.M., Edwards J., Jeffriess H., Scorza E. (1989) Fluoxetine versus amitriptyline in adult outpatients with major depression. Curr Ther Res 45: 821-832
42. Feighner J.P. (1985) A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. J Clin Psychiatr 46: 369-372
43. Feighner J.P. (1992) A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients. Int Clin Psychopharmacol 6: 31-35
44. Feighner J.P., Cohn J.B. (1985) Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatr 46: 20-25
45. Feighner J.P., Boyer W.F. (1989) Paroxetine in the treatment of depression: a comparison with imipramine and placebo. Acta Psychiatr Scand 80: 125-129
46. Feighner J.P., Robins E., Guse S.B., Woodruff R.A., Winokur G., Munos R. (1972) Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatr 26: 57-63
47. Feighner J.P., Boyer W.F., Meredith C.H., Hendrickson G.G. (1989a) A placebo-controlled in-patient comparison of fluvoxamine maleate and imipramine in major depression. Int Clin Psychopharmacol 4: 239-244
48. Feighner J.P., Boyer W.F., Merideth C.H., Hendrickson G.G. (1989b) A double-blind comparison of fluoxetine, imipramine and placebo in out-patients with major depression. Int Clin Psychopharmacol 4: 127-134
49. Feighner J.P., Cohn J.B., Fabre L.F., Fieve R.R., Mendels J., Shrivastava R.K., Dunbar G.C. (1993) A study comparing paroxetine, placebo and imipramine in depressed patients. J Affective Disord 28: 71-79
50. Ferreri M. (1989) Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders. Int Clin Psychopharmacol 4: 97-101
51. Filip V., Hoschl C., Karen P., Seifertova D., Bornova L., Praskova H., Prasko J. (1993) Predicting therapeutic results with levoprotiline and maprotiline in major depression: the role of the outcome criteria. Br J Psychiatr 163(Suppl 21): 35-38
52. Fontaine R. (1991) The efficacy and safety of sertraline versus imipramine in out-patients with major depression: a six month double-blind, parallel multicenter study. Eur Neuropsychopharmacol 1: 75
53. Gagiano C.A., Muller P G M, Fourie J., Le Roux J.F. (1989) The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients. Acta Psychiatr Scand 80: 130-131
54. Gasperini M., Gatti F., Bellini L., Anniverno R., Smeraldi E. (1992) Perspectives in clinical psychopharmacology of amitriptyline and fluvoxamine: a double-blind study in depressed inpatients. Pharmacopsychiatry 26: 186-192
55. Ginestet D., Alby J.M., Besancon G., Carrier G., Cordier B., Degiovanni A., Dufour H., Ferreri M., Leger L., Moron P., Pellet J., Perivier E., Singer L., Ulliac G. (1989) Fluoxetine in endogenous depression and melancholia versus clomipramine. Int Clin Psychopharmacol 4: 37-40
56. Gonella G., Baignoli G., Ecari U. (1990) Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study. Curr Med Res Opin 12: 177-184
57. Gravem A., Amthor K.F., Astrup C., Elgen K., Gjessing L.R., Gunby B., Pettersen R.D., Kyrdalen L., Vaadal J., Ofsti E., Aarvold A. (1987) A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients. Acta Psychiatr Scand 75: 478-486
58. Grimsley S.R., Jann M.W. (1992) Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors. Clin Pharm 11: 930-956
59. Guelfi J.D., Dreyfus J.F., Pichot P., G E P E C E P (1983) A double-blind controlled clinical trial comparing fluvoxamine with imipramine. Br J Clin Pharmacol 15: 411S-417S
60. Guillibert E., Pellicier Y., Archambault J.C., Chabannes J.P., Clerc G., Desvilles M., Guibert M., Pagot R., Poisat J.L., Thobie Y. (1989) A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients. Acta Psychiatr Scand 80: 132-134
61. Guy W., Wilson W.H., Ban T.A., King D.L., Manov G., Fjetland I.K. (1984) Double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression. Psychopharmacol Bull 20: 73-78
62. Hamilton M. (1960) A rating scale for depression. J Neurol, Neurosurg Psychiatr 23: 56-63
63. Harris B., Szulecka T.K., Anstee J.A. (1991) Fluvoxamine versus amitriptyline in depressed hospital out-patients: A multicentre double-blind comparative trial. Br J Clin Res 2: 89-99
64. Hedges L.V., Olkin I. (1985) Statistical methods for meta-analysis. Academic Press Inc., Orlando
65. Henry D.A., Wilson A. (1992) Meta-analysis. Part 1: an assessment of its aims, validity and reliability. Med J Aust 156: 31-38
66. Hutchinson D.R., Vince M. (1992) A double-blind study in general practice to compare the efficacy and tolerability of paroxetine and amitriptyline in depressed elderly patients. Am J Clin Res 1: 49-61
67. Hutchinson D.R., Tong S., Moon C A L, Vince M., Clarke A. (1991) A double blind study in General Practice to compare the efficacy and tolerability of paroxetine and amitriptyline in depressed elderly patients. Br J Clin Res 2: 43-57
68. Itil T.M., Shrivastava R.K., Mukherjee S., Coleman B.S., Michael S.T. (1983) A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression. Br J Clin Pharmacol 15: 433S-438S
69. Jenner P.N. (1992) Paroxetine: an overview of dosage, tolerability, and safety. Int Clin Psychopharmacol 6(Suppl 4): 69-80
70. Johnson A.M. (1991) The comparative pharmacological properties of selective serotonin re-uptake inhibitors in animals. In Feighner J P, Boyer W F (eds), Selective serotonin re-uptake inhibitors: the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline. John Wiley & Sons, Chichester, pp. 37-70
71. Judd F. (1991) Preliminary report of a double-blind study comparing fluoxetine and amitriptyline in the treatment of depression. J Am Med Assoc SEA. 31-33
72. Judd F.K., Moore K., Norman T.R., Burrows G.D., Gupta R.K., Parker G. (1993) A multicentre double blind trial of fluoxetine versus amitriptyline in the treatment of depressive illness. Aust NZ J Psychiatr 27: 49-55
73. Kasper S., Fuger J., Moller H-J. (1992) Comparative efficacy of antidepressants. Drugs 43: 11-23
74. Keegan D., Bowen R.C., Blackshaw S., Saleh S., Dayal N., Remillard F., Shrikhande S., Cebrian, Perez S. Boulton A., Richardson S., D'Arcy C. (1991) A comparison of fluoxetine and amitriptyline in the treatment of major depression. Int Clin Psychopharmacol 6: 117-124
75. Klok C.J., Brouwer G.J., Van Praag H.M., Doogan D. (1981) Fluvoxamine and clomipramine in depressed patients: a double-blind clinical study. Acta Psychiatr Scand 64: 1-11
76. Kuhs H., Rudolf G A E (1989) A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline. Acta Psychiatr Scand 80: 145-146
77. Laakmann G., Blaschke D., Engel R., Schwarz A. (1988) Fluoxetine vs amitriptyline in the treatment of depressed out-patients. Br J Psychiatr 153: 64-68
78. Lapierre Y.D., Browne M., Horn E., Oyewumi L.K., Sarantidis D., Roberts N., Badoe K., Tessier P. (1987) Treatment of major affective disorder with fluvoxamine. J Clin Psychiatr 48: 65-68
79. Levine S., Deo R., Mahadevan K. (1987) A comparative trial of a new antidepressant, fluoxetine. Br J Psychiatr 150: 653-655
80. Levine S., Deo R., Mahadevan K. (1989) A comparative trial of a new antidepressant, fluoxetine. Int Clin Psychopharmacol 4(Suppl 1): 41-45
81. Loeb C., Albano C., Gandolfo C. (1989) Fluoxetine versus imipramine. Int Clin Psychopharmacol 4: 75-79
82. Lund Laursen A., Mikkelsen P.L., Rasmussen S., le Fevre Honore P. (1985) Paroxetine in the treatment of depression—a randomized comparison with amitriptyline. Acta Psychiatr Scand 71: 249-255
83. Luscombe D.K. (1979) Pharmacokinetics of clomipramine. Br J Clin Pract Suppl 3: 35-50
84. Lydiard R.B., Lyle K.L., Morton W.A., Steele T.E., Kellner C., Laraia M.T., Ballenger J.C. (1989) Fluvoxamine, imipramine and placebo in the treatment of depressed out-patients: effects on depression. Psychopharmacol Bull 25: 68-70
85. Manna V., Martucci N., Agnoli A. (1989) Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders. Int Clin Psychopharmacol 4: 81-88
86. March J.S., Kobak K.A., Jefferson J.W., Mazza J., Greist J.H. (1990) A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in out-patients with major depression. J Clin Psychiatr 51: 200-202
87. Masco H.L., Sheetz M.S. (1985) Double-blind comparison of fluoxetine and amitriptyline in the treatment of major depressive illness. Adv Ther 2: 275-283
88. Mavissakalian M.R., Perel J.M. (1989) Imipramine dose-response relationship in panic disorder with agoraphobia. Arch Gen Psychiatr 46: 127-131
89. Miller H.J., Haug G. (1988) Secondary and meta-analysis of the efficacy of non-tricyclic antidepressants. Pharmacopsychiatry 21: 363-364
90. Moller H-J., Berzewski H., Eckmann F., Gonzalves N., Kissling W., Knorr W., Ressler P., Rudolf G A E, Steinmeyer E.M., Magyar I., Szucs R., Szilard J. (1993) Double-blind multicentre trial of paroxetine and amitriptyline in depressed inpatients. Pharmacopsychiatry 26: 75-78
91. Montgomery S.A. (1992) The advantages of paroxetine in different subgroups of depression. Int Clin Psychopharmacol 6(Suppl 4): 91-100
92. Montgomery S.A., Asberg M.A. (1979) A new depression scale designed to be sensitive to change. Br J Psychiatr 134: 382-389
93. Montgomery S.A., Pedersen V., Tanghoj P., Rasmussen C., Rioux P. (1994a) The optimal dosing regimen for citalopram—a meta-analysis of nine placebo-controlled studies. Int Clin Psychopharmacol 9(Suppl 1): 35-40
94. Montgomery S.A., Henry J., McDonald G., Dinan T., Lader M., Hindmarch I., Clare A., Nutt D. (1994b) Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol 9: 47-53
95. Mullin J.M., Pandita-Gunawardena V.R., Whitehead A.M. (1988) A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder. Br J Clin Pract 42: 51-55
96. Nathan R.S., Perel J.M., Pollack B.G., Kupfer D.J. (1990) The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine. J Clin Psychiatr 51: 367-372
97. Nelson J.C., Mazure C.M., Bowers M.B., Jatlow PI (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatr 48: 303-307
98. Nielsen B.M., Behnke K., Arup P., Christiansen P.E., Geisler A., Ipsen E., Maach-Moller B., Ohrberg S.C. (1993) A comparison of fluoxetine and imipramine in the treatment of out-patients with major depressive disorder. Acta Psychiatr Scand 87: 269-272
99. Nielsen O.A., Mosing I., Petersen J.S., Larsen T., Moller S.E., Manniche P.M., Skausig O.B. (1991) Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements. Acta Psychiatr Scand 84: 233-241
100. Noguera R., Altuna R., Alvarez E., Ayuso J.L., Casais L., Udina C. (1991) Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial. J Affective Disord 22: 119-124
101. Norton K R W, Sireling L.I., Bhat A.V., Rao B., Paykel E.S. (1984) A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients. J Affective Disord 7: 297-308
102. Ohrberg S., Christiansen P.E., Severin B., Calberg H., Nilakantan B., Borup B., Sogaard A., Larsen J., Loldrup D., Bahr B., Siebuhr N., Gregersen B., Jacobsen F., Liljestrom M., Manniche P.M., Bech P. (1992) Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice. Acta Psychiatr Scand 86: 437-444
103. Ottevanger E.A. (1991) The efficacy of fluvoxamine in patients with severe depression. Br J Clin Res 2: 125-132
104. Ottevanger E.A. (1993) A meta-analysis of published fluvoxamine studies in hospitalized depressed patients: a comparison with tri- and tetracyclic antidepressants. Eur Neuropsychopharmacol 3: 327
105. Pande A.C., Sayler M.E. (1993) Fluoxetine—a clinical and research update: severity of depression and response to fluoxetine. Int Clin Psychopharmacol 8: 243-245
106. Peselow E.D., Filippi A.M., Goodnick P., Barouche F., Fieve R.R. (1989) The short and long term efficacy of paroxetine HCl: a data from a six-week double-blind parallel design trial vs imipramine and placebo. Psychopharmacol Bull 25: 267-271
107. Peto R.E. (1987) Why do we need systematic overviews of randomized trials? Stat Med 6: 233-240
108. Poelinger W., Haber H. (1989) Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders. Int Clin Psychopharmacol 4: 47-50
109. Rahman M.K., Akhtar M.J., Savla N.C., Sharma R.R., Kellett J.M., Ashford J.J. (1991) A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients. Br J Clin Pharmacol 45: 255-258
110. Reimherr F.W., Chouinard G., Cohn C.K., Cole J.O., Itil T.M., LaPierre Y.D., Masco H.L., Mendels J. (1990) Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in out-patients with major depression. J Clin Psychiatr 51: 18-27
111. Ropert R. (1989) Fluoxetine versus clomipramine in major depressive disorders. Int Clin Psychopharmacol 4: 89-95
112. Ross S.B., Renyi A.L. (1975a) Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3H-noradrenaline and 14C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. Acta Pharmacol Toxicol 36: 382-394
113. Ross S.B., Renyi A.L. (1975b) Tricyclic antidepressant agents. II. Effect of oral administration on the uptake of 3H-noradrenaline and 14C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat. Acta Pharmacol Toxicol 36: 395-408
114. Roth D., Mattes J., Sheehan K.H., Sheehan D.V. (1990) A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression. Prog Neuro-Psychopharmacol Biol Psychiatr 14: 929-939
115. Seth R., Jennings A.L., Bindman J., Phillips J., Bergmann K. (1992) Combination treatment of noradrenalin and serotonin reuptake inhibitors in resistant depression. Br J Psychiatr 161: 562-565
116. Shaw D.M. (1986) A comparison of the antidepressant action of citalopram and amitriptyline. Br J Psychiatr 149: 515-517
117. Snaith P. (1993) What do depression rating scales measure? Br J Psychiatr 163: 293-298
118. Song F., Freemantle N., Sheldon T.A., House A., Watson P., Long A., Mason J. (1993) Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. Br Med J 306: 683-687
119. South Wales Antidepressant Drug Trial Group (1988) A double-blind multi-centre trial of fluoxetine and dothiepin in major depressive illness. Int Clin Psychopharmacol 3: 75-81
120. Spitzer R., Endicott J., Robins E. (1975) Research diagnostic criteria. New York State Psychiatric Institute, New York
121. Stark P., Hardison C.D. (1985) A review of multicenter controlled studies of fluoxetine vs imipramine and placebo in out-patients with major depressive disorder. J Clin Psychiatr 46: 53-58
122. Tamminen T T A, Lehtinen V.V. (1989) A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders. Int Clin Psychopharmacol 4: 51-56
123. Taneri Z., Kohler R. (1989) Fluoxetine versus nomifensine in outpatients with neurotic or reactive depression disorder. Int Clin Psychopharmacol 4: 56-61
124. Thompson C. (1991) Sertraline in a primary care setting. In Racagni G (ed.), Biological psychiatry. Elsevier Science Publishers, pp.863-865
125. Thompson C., Thompson C.M. (1989) The prescribing of antidepressants in General Practice. II. A placebo-controlled trial of low-dose dothiepin. Hum Psychopharmacol 4: 191-204
126. Tignol J., Stoker M.J., Dunbar G.C. (1992) Paroxetine in the treatment of melancholia and severe depression. Int Clin Psychopharmacol 7: 91-94
127. Timmerman L., De Beurs P., Tan B.K., Leijnse-Ybema H., Sanchez C., Hopfner Petersen H.E., Cohen-Stuart M.H. (1987) A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients. Int Clin Psychopharmacol 2: 239-253
128. Weilburg J.B., Rosenbaum J.F., Biederman J., Sachs G.S., Pollack M.H., Kelly K. (1989) Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatr 50: 447-449
129. Weilburg J.B., Rosenbaum J.F., Meiltzer-Brody S., Shushtari J. (1991) Tricyclic augmentation of fluoxetine. Ann Clin Psychol 3: 209-213
130. Wilson A., Henry D.A. (1992) Meta-analysis. Part 2: assessing the quality of published meta-analyses. Med J Aust 156: 173-187
131. Young J P R, Coleman A., Lader M.H. (1987) A controlled comparison of fluoxetine and amitriptyline in depressed outpatients. Br J Psychiatr 151: 337-340